Picture of Emmaus Life Sciences logo

EMMA — Emmaus Life Sciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSuper Stock

Brief: Mynd Analytics Provides Qtrly Revenue $459,900 Versus $31,900

May 15 (Reuters) - MYnd Analytics Inc  MYND.O :
    * MYND ANALYTICS PROVIDES BUSINESS UPDATE AND REPORTS
SIGNIFICANT
INCREASE IN REVENUES FOR THE SECOND QUARTER OF 2018
    * MYND ANALYTICS INC - NET LOSS FOR THREE MONTHS ENDED MARCH
31,
2018 WAS APPROXIMATELY $2.7 MILLION
    * MYND ANALYTICS INC - QTRLY REVENUE $459,900 VERSUS $31,900

Source text for Eikon:  ID:nGNX58qHk2 
Further company coverage:  MYND.O 

 (Reuters.Briefs@thomsonreuters.com)

Recent news on Emmaus Life Sciences

See all news